HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women
Jeanne Marrazzo(St. Vincent's Birmingham), Connie Celum(University of Washington), Michael Kiragu(LVCT Health), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Marissa Becker(University of Manitoba), Sushena Reza‐Paul, Janet J. Myers(University of California, San Francisco), Jared M. Baeten(University of Washington), Faith Ussery(Centers for Disease Control and Prevention), Christoph C Carter(Centre for the AIDS Programme of Research in South Africa), Melanie de Boer(Gilead Sciences (United States)), Moupali Das(University of California, San Francisco), Juan Yang(Affiliated Hospital of Southwest Medical University), Ashley A. Leech(Vanderbilt University Medical Center), Tao Li(Zhengzhou University), Allan W. Taylor
Cited by 79
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings
|PsycEXTRA Dataset|2006|3k
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
|New England Journal of Medicine|2015|1.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891